Provided by Tiger Trade Technology Pte. Ltd.

Abivax S.A.

115.36
+0.40500.35%
Volume:675.39K
Turnover:77.39M
Market Cap:10.04B
PE:-22.11
High:115.92
Open:114.00
Low:113.30
Close:114.95
52wk High:148.83
52wk Low:69.81
Shares:87.05M
Float Shares:76.46M
Volume Ratio:1.55
T/O Rate:0.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.2168
EPS(LYR):-5.6758
ROE:-157.07%
ROA:-44.65%
PB:20.04
PE(LYR):-20.32

Loading ...

Abivax 2025 Net Loss Widens

MT Newswires Live
·
Mar 24

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 23

LifeSci Capital Sticks to Their Buy Rating for Abivax SA Sponsored ADR (ABVX)

TIPRANKS
·
Mar 21

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 20

Abivax SA expected to post a loss of €1.28 a share - Earnings Preview

Reuters
·
Mar 20

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 18

European Equities Traded in the US as American Depositary Receipts Higher Monday

MT Newswires Live
·
Mar 16

Jefferies Initiates Abivax at Buy With $160 Price Target

MT Newswires Live
·
Mar 16

U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Cogent Biosciences, Summit Therapeutics

Reuters
·
Mar 16

Earning Preview: Abivax S.A. this quarter’s revenue is expected to decrease by 29.21%, and institutional views are bullish

Earnings Agent
·
Mar 16

Abivax SA Sponsored ADR (ABVX) Initiated with a Buy at Leerink Partners

TIPRANKS
·
Mar 16

Abivax initiated with a Buy at Jefferies

TIPRANKS
·
Mar 16

Barclays Remains a Buy on Abivax SA Sponsored ADR (ABVX)

TIPRANKS
·
Mar 13

Sector Update: Health Care Stocks Retreat Late Afternoon

MT Newswires Live
·
Mar 13

Sector Update: Health Care Stocks Lower in Afternoon Trading

MT Newswires Live
·
Mar 13

Market Chatter: Abivax Denies La Lettre Report of AstraZeneca Exclusivity

MT Newswires Live
·
Mar 12

Abivax Denies La Lettre Report of AstraZeneca Exclusivity, Bloomberg Reports

MT Newswires Live
·
Mar 12

Abivax jumps 15% to $129.11 after report of exclusivity with AstraZeneca

TIPRANKS
·
Mar 12

BUZZ-Abivax shares soar after renewed takeover rumours

Reuters
·
Mar 12

Wedbush Initiates Abivax at Underperform With $110 Price Target

MT Newswires Live
·
Feb 24